Cervical Epidural Injection
Proceduresensitivity, specificity, positive predictive value, negative predictive value
NCT Number: NCT02838654
The purpose of this study is to analyze the reliability of epidural wave form during cerivical epidural injection.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Observational
The epidural space can be confirmed by loss of resistance (LOR) technique. However, LOR has very low specificity, although its sensitivity is high. Especially, cysts between ligaments, clefts in ligamentum flavum, paraspinal muscle and nonspecific spaces between muscles make false LOR.
Epidural wave form analysis (EWA) is very simple and reliable method which can substitue the LOR technique. If the epidural needle is located correctly in the epidural space, the investigators can observe a pulsatile wave and this pulsatile wave corresponds to arterial wave. Generally, sensitivity of EWA through needle is known to be superior to the sensitivity of EWA through catheter and most studies were focused on catheter EWA.
Cervical epidural space shows high false LOR rate and Lee et al demonstrated that false LOR at cervical epidural space was 68.7%. Therefore, nonspecificity of LOR technique require substitution method which can confirm epidural space.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
sensitivity, specificity, positive predictive value, negative predictive value
Time frame: 1 minute after the completion of the epidural injection
Keimyung University Dongsan Medical Center
Other
Reliability of Epidural Waveform Analysis for Cervical Epidural Blocks
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03242525
Analysis, Event History, Blood
Frankfurt am Main, Hesse, Germany
View Trial DetailsNCT03245294
Analysis, Event History
Daegu, South Korea
View Trial DetailsNCT02919657
Absorption; Disorder, Protein, Analysis, Event History
View Trial DetailsNCT01423942
Analysis, Event History
Haifa, Israel
View Trial Details